AU1971200A - Assays for compounds which increase phospholipase a2 activity - Google Patents
Assays for compounds which increase phospholipase a2 activityInfo
- Publication number
- AU1971200A AU1971200A AU19712/00A AU1971200A AU1971200A AU 1971200 A AU1971200 A AU 1971200A AU 19712/00 A AU19712/00 A AU 19712/00A AU 1971200 A AU1971200 A AU 1971200A AU 1971200 A AU1971200 A AU 1971200A
- Authority
- AU
- Australia
- Prior art keywords
- assays
- activity
- compounds
- phospholipase
- increase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102100037611 Lysophospholipase Human genes 0.000 title 1
- 108010058864 Phospholipases A2 Proteins 0.000 title 1
- 238000003556 assay Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Psychiatry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9826899.8A GB9826899D0 (en) | 1998-12-08 | 1998-12-08 | Methods to treat depression and other psychiatric disorders and assays for compounds |
GB9826899 | 1998-12-08 | ||
PCT/EP1999/009546 WO2000034791A1 (en) | 1998-12-08 | 1999-12-07 | Assays for compounds which increase phospholipase a2 activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1971200A true AU1971200A (en) | 2000-06-26 |
Family
ID=10843783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19712/00A Abandoned AU1971200A (en) | 1998-12-08 | 1999-12-07 | Assays for compounds which increase phospholipase a2 activity |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1137949A1 (en) |
JP (1) | JP2002532687A (en) |
AU (1) | AU1971200A (en) |
CA (1) | CA2353616A1 (en) |
GB (1) | GB9826899D0 (en) |
WO (1) | WO2000034791A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0001703D0 (en) * | 2000-01-25 | 2000-03-15 | Glaxo Group Ltd | Assay |
KR20030046896A (en) * | 2001-12-07 | 2003-06-18 | 학교법인 포항공과대학교 | Transformant having a recombinant reporter gene whose expression being regulated by glucocorticoid and method for screening analogue and inhibitor of glucocorticoid using same |
JPWO2003071271A1 (en) * | 2002-02-21 | 2005-06-16 | 東京瓦斯株式会社 | Method for screening a test drug for evaluating the pharmacological action of a pharmaceutical product, and a drug comprising an enzyme, an enzyme inhibitor or a receptor ligand and / or a prodrug thereof having a high administration effect and / or a small side effect And reagents |
CN104777314B (en) * | 2009-08-12 | 2017-01-04 | 福满代谢组技术有限公司 | The biomarker of depression, the assay method of biomarker of depression, computer program and record medium |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
US5464754A (en) * | 1993-08-17 | 1995-11-07 | The Regents Of The University Of California | Assay and substrate for arachidonoyl-specific phospholipase A2 |
-
1998
- 1998-12-08 GB GBGB9826899.8A patent/GB9826899D0/en not_active Ceased
-
1999
- 1999-12-07 JP JP2000587194A patent/JP2002532687A/en active Pending
- 1999-12-07 CA CA002353616A patent/CA2353616A1/en not_active Abandoned
- 1999-12-07 WO PCT/EP1999/009546 patent/WO2000034791A1/en not_active Application Discontinuation
- 1999-12-07 AU AU19712/00A patent/AU1971200A/en not_active Abandoned
- 1999-12-07 EP EP99963400A patent/EP1137949A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000034791A1 (en) | 2000-06-15 |
EP1137949A1 (en) | 2001-10-04 |
CA2353616A1 (en) | 2000-06-15 |
JP2002532687A (en) | 2002-10-02 |
GB9826899D0 (en) | 1999-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0928996A3 (en) | Toner preparation processes | |
EP0928991A3 (en) | Toner preparation processes | |
EP0928992A3 (en) | Toner preparation processes | |
AU8547198A (en) | Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase | |
AU5052199A (en) | Chemical compounds | |
AU6804098A (en) | Triazinylaminostilbene compounds | |
AU4260199A (en) | Novel compounds | |
AU1424200A (en) | Compounds | |
AU4501699A (en) | Aminoazole compounds | |
AU5637499A (en) | Chemical compounds iii | |
AU2014800A (en) | Novel compounds | |
AU5980899A (en) | Novel compounds | |
AU6104599A (en) | Chemical compounds viii | |
AU1434500A (en) | Compounds | |
AU4814699A (en) | Novel compounds | |
AU7124598A (en) | Polymer-platinum compounds | |
AUPP042397A0 (en) | 5-arylpyrazole compounds | |
AU4835599A (en) | Assay for homocysteine | |
AU1950899A (en) | Compounds for increased bioavailability | |
AU1971200A (en) | Assays for compounds which increase phospholipase a2 activity | |
AU3843899A (en) | Apoptosis-inducing compounds | |
AU1090800A (en) | Linker-assisted immunoassay for glyphosate | |
AU2187799A (en) | Novel taxaneterpine compounds | |
AU8019998A (en) | Fluoromethoximino compounds | |
AU1872900A (en) | Chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |